These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35528200)

  • 1. Integrative genome-wide analysis reveals EIF3A as a key downstream regulator of translational repressor protein Musashi 2 (MSI2).
    Karmakar S; Ramirez O; Paul KV; Gupta AK; Kumari V; Botti V; de Los Mozos IR; Neuenkirchen N; Ross RJ; Karanicolas J; Neugebauer KM; Pillai MM
    NAR Cancer; 2022 Jun; 4(2):zcac015. PubMed ID: 35528200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide analysis of Musashi-2 targets reveals novel functions in governing epithelial cell migration.
    Bennett CG; Riemondy K; Chapnick DA; Bunker E; Liu X; Kuersten S; Yi R
    Nucleic Acids Res; 2016 May; 44(8):3788-800. PubMed ID: 27034466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptome-wide analysis uncovers the targets of the RNA-binding protein MSI2 and effects of MSI2's RNA-binding activity on IL-6 signaling.
    Duggimpudi S; Kloetgen A; Maney SK; Münch PC; Hezaveh K; Shaykhalishahi H; Hoyer W; McHardy AC; Lang PA; Borkhardt A; Hoell JI
    J Biol Chem; 2018 Oct; 293(40):15359-15369. PubMed ID: 30126842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small Molecule Palmatine Targeting Musashi-2 in Colorectal Cancer.
    Zhang X; Su K; Liu Y; Zhu D; Pan Y; Ke X; Qu Y
    Front Pharmacol; 2021; 12():793449. PubMed ID: 35153752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal and solution structures of human oncoprotein Musashi-2 N-terminal RNA recognition motif 1.
    Lan L; Xing M; Kashipathy M; Douglas J; Gao P; Battaile K; Hanzlik R; Lovell S; Xu L
    Proteins; 2020 Apr; 88(4):573-583. PubMed ID: 31603583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developmental expression of Musashi-1 and Musashi-2 RNA-binding proteins during spermatogenesis: analysis of the deleterious effects of dysregulated expression.
    Sutherland JM; Fraser BA; Sobinoff AP; Pye VJ; Davidson TL; Siddall NA; Koopman P; Hime GR; McLaughlin EA
    Biol Reprod; 2014 May; 90(5):92. PubMed ID: 24671879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Musashi-2 (MSI2) regulates epidermal growth factor receptor (EGFR) expression and response to EGFR inhibitors in EGFR-mutated non-small cell lung cancer (NSCLC).
    Makhov P; Bychkov I; Faezov B; Deneka A; Kudinov A; Nicolas E; Brebion R; Avril E; Cai KQ; Kharin LV; Voloshin M; Frantsiyants E; Karnaukhov N; Kit OI; Topchu I; Fazliyeva R; Nikonova AS; Serebriiskii IG; Borghaei H; Edelman M; Dulaimi E; Golemis EA; Boumber Y
    Oncogenesis; 2021 Mar; 10(3):29. PubMed ID: 33723247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Musashi-2 (MSI2) regulation of DNA damage response in lung cancer.
    Bychkov I; Deneka A; Topchu I; Pangeni RP; Lengner C; Karanicolas J; Golemis EA; Makhov P; Boumber Y
    bioRxiv; 2023 Jun; ():. PubMed ID: 37398283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human oncoprotein Musashi-2 N-terminal RNA recognition motif backbone assignment and identification of RNA-binding pocket.
    Lan L; Xing M; Douglas JT; Gao P; Hanzlik RP; Xu L
    Oncotarget; 2017 Dec; 8(63):106587-106597. PubMed ID: 29290973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Musashi-2 (MSI2) supports TGF-β signaling and inhibits claudins to promote non-small cell lung cancer (NSCLC) metastasis.
    Kudinov AE; Deneka A; Nikonova AS; Beck TN; Ahn YH; Liu X; Martinez CF; Schultz FA; Reynolds S; Yang DH; Cai KQ; Yaghmour KM; Baker KA; Egleston BL; Nicolas E; Chikwem A; Andrianov G; Singh S; Borghaei H; Serebriiskii IG; Gibbons DL; Kurie JM; Golemis EA; Boumber Y
    Proc Natl Acad Sci U S A; 2016 Jun; 113(25):6955-60. PubMed ID: 27274057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional screen of MSI2 interactors identifies an essential role for SYNCRIP in myeloid leukemia stem cells.
    Vu LP; Prieto C; Amin EM; Chhangawala S; Krivtsov A; Calvo-Vidal MN; Chou T; Chow A; Minuesa G; Park SM; Barlowe TS; Taggart J; Tivnan P; Deering RP; Chu LP; Kwon JA; Meydan C; Perales-Paton J; Arshi A; Gönen M; Famulare C; Patel M; Paietta E; Tallman MS; Lu Y; Glass J; Garret-Bakelman FE; Melnick A; Levine R; Al-Shahrour F; Järås M; Hacohen N; Hwang A; Garippa R; Lengner CJ; Armstrong SA; Cerchietti L; Cowley GS; Root D; Doench J; Leslie C; Ebert BL; Kharas MG
    Nat Genet; 2017 Jun; 49(6):866-875. PubMed ID: 28436985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Musashi RNA-Binding Proteins as Cancer Drivers and Novel Therapeutic Targets.
    Kudinov AE; Karanicolas J; Golemis EA; Boumber Y
    Clin Cancer Res; 2017 May; 23(9):2143-2153. PubMed ID: 28143872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA-binding protein MSI2 isoforms expression and regulation in progression of triple-negative breast cancer.
    Li M; Li AQ; Zhou SL; Lv H; Wei P; Yang WT
    J Exp Clin Cancer Res; 2020 May; 39(1):92. PubMed ID: 32448269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3'READS + RIP defines differential Staufen1 binding to alternative 3'UTR isoforms and reveals structures and sequence motifs influencing binding and polysome association.
    Zheng D; Cho H; Wang W; Rambout X; Tian B; Maquat LE
    RNA; 2020 Nov; 26(11):1621-1636. PubMed ID: 32796083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crosslinking-immunoprecipitation (iCLIP) analysis reveals global regulatory roles of hnRNP L.
    Rossbach O; Hung LH; Khrameeva E; Schreiner S; König J; Curk T; Zupan B; Ule J; Gelfand MS; Bindereif A
    RNA Biol; 2014; 11(2):146-55. PubMed ID: 24526010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Musashi RNA-binding protein 2 regulates estrogen receptor 1 function in breast cancer.
    Kang MH; Jeong KJ; Kim WY; Lee HJ; Gong G; Suh N; Győrffy B; Kim S; Jeong SY; Mills GB; Park YY
    Oncogene; 2017 Mar; 36(12):1745-1752. PubMed ID: 27593929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translational regulation of Chk1 expression by eIF3a via interaction with the RNA-binding protein HuR.
    Dong Z; Liu J; Zhang JT
    Biochem J; 2020 May; 477(10):1939-1950. PubMed ID: 32391557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of VEGFR2 and AKT Signaling by Musashi-2 in Lung Cancer.
    Bychkov I; Topchu I; Makhov P; Kudinov A; Patel JD; Boumber Y
    Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37173995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Musashi-2 potentiates colorectal cancer immune infiltration by regulating the post-translational modifications of HMGB1 to promote DCs maturation and migration.
    Meng X; Na R; Peng X; Li H; Ouyang W; Zhou W; You X; Li Y; Pu X; Zhang K; Xia J; Wang J; Tang H; Zhuang G; Peng Z
    Cell Commun Signal; 2024 Feb; 22(1):117. PubMed ID: 38347600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Musashi 2 (MSI2) expression as an independent prognostic biomarker in non-small cell lung cancer (NSCLC).
    Topchu I; Karnaukhov N; Mazitova A; Yugai V; Voloshin M; Tikhomirova M; Kit O; Frantsiyants E; Kharin L; Airapetova T; Ratner E; Sabirov A; Abramova Z; Serebriiskii I; Boumber Y; Deneka A
    J Thorac Dis; 2021 Mar; 13(3):1370-1379. PubMed ID: 33841930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.